News from Beckman Coulter A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 15, 2014, 11:15 ET Beckman Coulter Diagnostics y Seegene anuncian un acuerdo de suministro de múltiples reagentes para VERIS

- Beckman Coulter Diagnostics y Seegene anuncian un acuerdo de suministro de múltiples reagentes para el sistema de diagnosis molecular...


Nov 14, 2014, 10:22 ET Beckman Coulter Diagnostics und Seegene geben Abschluss eines Liefervertrages für Multiplex-Reagenzien für das Molekulardiagnosesystem VERIS bekannt

 Beckman Coulter Diagnostics, weltweit führend in der IVD-Branche und Seegene Inc. (096530.KQ), führender Entwickler von...


Nov 14, 2014, 09:01 ET Beckman Coulter Diagnostics et Seegene annoncent la conclusion d'un accord de fourniture portant sur des réactants multiplexes destinés au système de diagnostic moléculaire VERIS

 Beckman Coulter Diagnostics, leader mondial dans le secteur du diagnostic in vitro, et Seegene Inc. (096530.KQ), développeur leader...


Nov 13, 2014, 17:00 ET Beckman Coulter Diagnostics and Seegene Announce Supply Agreement for Multiplex Reagents for VERIS Molecular Diagnostics System

 Beckman Coulter Diagnostics, a world leader in the IVD industry, and Seegene Inc. (096530.KQ), a leading developer of multiplex PCR...


Jul 16, 2014, 16:00 ET Beckman Coulter to Acquire Siemens Healthcare Diagnostics' Clinical Microbiology Business

Beckman Coulter, an indirect wholly-owned subsidiary of Danaher Corporation (NYSE:DHR), announced today that it has entered into a definitive...


Apr 24, 2014, 08:00 ET New Prostate Cancer Blood Test Now Available in the US

 Beckman Coulter Diagnostics, a global leader in prostate cancer diagnostics, announces national availability of the Prostate Health Index...


Jun 19, 2013, 09:40 ET Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System

 Continuing its long history of proven clinical performance in diagnosis of myocardial infarction (MI), Beckman Coulter, Inc. announces the...


Nov 29, 2005, 00:00 ET Beckman Coulter Subsidiary Agencourt Bioscience Enters Into Supply Agreement With Affymetrix

FULLERTON, Calif., Nov. 29 /PRNewswire-FirstCall/ -- Agencourt Bioscience Corporation, a wholly owned subsidiary of Beckman Coulter (NYSE: BEC),...


Sep 28, 2005, 01:00 ET Beckman Coulter Launches New Agencourt(R) DNA Isolation Kit

FULLERTON, Calif., Sept. 28 /PRNewswire-FirstCall/ -- Agencourt Bioscience Corporation, a wholly owned subsidiary of Beckman Coulter (NYSE: BEC),...


Sep 16, 2005, 01:00 ET Beckman Coulter Teams With Prostate Cancer Education Council to Sponsor Prostate Cancer Awareness Week

FULLERTON, Calif., Sept. 16 /PRNewswire/ -- Beckman Coulter, Inc. has joined forces with the Prostate Cancer Education Council (PCEC) to provide...


Jan 28, 2005, 00:00 ET Beckman Coulter Announces 2004 Sales Growth of 9.8%

FULLERTON, Calif., Jan. 28 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC) announced today fourth quarter and year ended December 31,...


Jan 21, 2005, 00:00 ET Beckman Coulter Names Scott Garrett Chief Executive Officer

FULLERTON, Calif., Jan. 21 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC) announced today that Scott Garrett has been named chief...


Jul 08, 2004, 01:00 ET Value of PSA and Free PSA Tests Validated in New Prostate Cancer Guidelines

FULLERTON, Calif., July 8 /PRNewswire-FirstCall/ -- New guidelines from the independent National Comprehensive Cancer Network (NCCN) strongly...